Screening for prostate cancer: a Cochrane systematic review.
about
Lycopene for the prevention of prostate cancerMortality results from the Göteborg randomised population-based prostate-cancer screening trialGynaecological aspects of the treatment and follow-up of transsexual men and women.Targeting monoamine oxidase A in advanced prostate cancer.Quality-of-life effects of prostate-specific antigen screening.The Japanese guideline for prostate cancer screening.Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes(18)F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer.The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.What we have learned from randomized trials of prostate cancer screening.The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?Nomogram for prediction of prostate cancer with serum prostate specific antigen less than 10 ng/mL.Epstein criteria for insignificant prostate cancer.Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials.Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer.Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.The role of transrectal ultrasound in the diagnosis of prostate cancer: new contributions.Population-based Prostate Cancer Screening in KazakhstanAre we worrying about the right men and are the right men feeling worried? Conscious but not unconscious prostate anxiety predicts screening among men from three ethnic groups.Prostate cancer screening with PSA: "Aequanimitas".Men's perspectives of prostate cancer screening: A systematic review of qualitative studies.PSA screening for prostate cancer.
P2860
Q24241585-B456DFA5-F480-4864-93F6-605CDCA89E0EQ33873969-86D99935-EB7D-451D-B14E-F3E0E3674D3EQ34132096-D98A0807-7735-4696-9709-4AB4C1D1833AQ34154664-126FAFB5-82AD-4AC8-B342-11FE3C017128Q34294102-109EC9F2-32A4-42AF-A2F7-998568664F0CQ34606240-4DBC64E0-7C6B-4130-9AB0-B4DC44BD46A4Q35212795-D72EADDB-993F-40CD-B986-97B23D9CED29Q36502692-BF698B61-9663-449E-8653-5895E0232EB7Q36686892-46CE9BA8-D893-4F88-90C9-41E795BC6F65Q37084639-C17FE6F2-73C5-4637-9B89-3DE867AE44C6Q37260341-9F88AF6C-8981-4026-8A69-C9671AFCA31BQ37622189-8A2FC340-FAC2-42F2-95E2-907CC8653068Q37841742-BF56583F-F314-4DE4-8AC5-AD2DFE9DA05EQ38321672-281D0182-A63B-429F-AF64-2E77D5E2A1A4Q38379141-1C9B4E6C-C62D-447B-B7DF-012C25EBC094Q38771232-6490C879-B07C-47C4-AE11-62ED98A64EDCQ39026533-B64F9199-5403-47BA-A2B3-B3F2496E6299Q41466522-8616078C-1BCC-4D90-86D3-97FED8C39D8FQ43552755-AD35A41B-BC6C-4332-BBCD-B131492836D8Q46200398-47EAC8EE-874D-4A8C-8A62-255127E01E1CQ47188433-F0E95C7D-11B8-4ABD-AE8D-314920A1C5B1Q47700583-5FBF1DFD-851B-4CFF-97D6-005DAE71A838
P2860
Screening for prostate cancer: a Cochrane systematic review.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Screening for prostate cancer: a Cochrane systematic review.
@ast
Screening for prostate cancer: a Cochrane systematic review.
@en
type
label
Screening for prostate cancer: a Cochrane systematic review.
@ast
Screening for prostate cancer: a Cochrane systematic review.
@en
prefLabel
Screening for prostate cancer: a Cochrane systematic review.
@ast
Screening for prostate cancer: a Cochrane systematic review.
@en
P2093
P1476
Screening for prostate cancer: a Cochrane systematic review
@en
P2093
Denise O'Connor
Sally Green
Timothy Wilt
P2860
P2888
P304
P356
10.1007/S10552-006-0087-6
P50
P577
2007-01-06T00:00:00Z